Kari Poikolainen. Show Affiliations »
Abstract
Mesh: See more » Anxiety Disorders/complicationsDepressive Disorder/complicationsHallucinogensHumansN-Methyl-3,4-methylenedioxyamphetamineSubstance-Related Disorders/psychology
Substances: See more » HallucinogensN-Methyl-3,4-methylenedioxyamphetamine
Year: 2006 PMID: 16601017 PMCID: PMC1432142 DOI: 10.1136/bmj.332.7545.803
Source DB: PubMed Journal: BMJ ISSN: 0959-8138